Really.... NBIX has a market capital of 4B and it spiked 25% on FDA approval recently? I would expect more from RAP, although it's market capital is "high", it's quite low in the biotech stock field.
Ann: ResApp Provides SMARTCOUGH-C May Study Update, page-109
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 35 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)